Immutep (IMMP) Gains from Investment Securities (2015 - 2024)
Immutep's (IMMP) quarterly Gains from Investment Securities came in at $82587.0 in Q2 2024, down 11.13% YoY from $92934.2 in Q3 2023, and down 11.13% on a QoQ basis from $92934.2 in Q2 2023.
Immutep (IMMP) Gains from Investment Securities (2015 - 2024) Analysis & Trends
Immutep (IMMP) has 7 years of Gains from Investment Securities data on file, last reported at $82587.0 in Q2 2024.
- Quarterly Gains from Investment Securities fell 11.13% year-over-year to $82587.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $1.6 million (down 22.88% YoY) and the FY2024 annual result came in at $82587.0, down 11.13% from the prior year.
- Gains from Investment Securities fell to $82587.0 in Q2 2024, from $92934.2 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $751378.1 in Q2 2020 to a low of $82587.0 in Q2 2024.
- A 3-year average of $308966.4 and a median of $92934.2 in 2023 frame the typical range for Gains from Investment Securities.
- Annual changes were most pronounced in 2020 — Gains from Investment Securities increased 7.6% — and 2024, when it decreased 11.13%.
- Tracing IMMP's Gains from Investment Securities over 3 years: stood at $751378.1 in 2020, then slumped by 87.63% to $92934.2 in 2023, then slipped by 11.13% to $82587.0 in 2024.
- The last three Gains from Investment Securities figures came in at $82587.0 (Q2 2024), $92934.2 (Q2 2023), and $751378.1 (Q2 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Immutep | 56.46 Mn | -8.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 82,586.97 |
| Jun 30, 2024 | 82,586.97 |
| Jun 30, 2023 | 92,934.18 |
| Jun 30, 2023 | 92,934.18 |
| Jun 30, 2020 | 751,378.14 |
| Jun 30, 2020 | 751,378.14 |
| Jun 30, 2019 | 698,283.30 |
| Jun 30, 2019 | 698,283.30 |
| Jun 30, 2017 | 564,771.95 |
| Jun 30, 2017 | 564,771.95 |
| Jun 30, 2016 | 453,724.02 |
| Jun 30, 2016 | 453,724.02 |
| Jun 30, 2015 | 4,011.50 |
| Jun 30, 2015 | 4,011.50 |